Literature DB >> 12606247

Homeopathic use of modern medicines: utilisation of the curative rebound effect.

Marcus Zulian Teixeira1.   

Abstract

Homeopathy is a therapeutic method based on the application of the similitude principle, utilising medicinal substances that produce effects that are similar to the symptoms being treated. In this process, the organism is stimulated to react against its own disturbances through a vital (paradoxical, secondary or homeostatic) reaction, oriented by the primary effect of the used drug. This effect should have properties that are similar to the symptom that is being treated. This secondary reaction of the organism to a medicinal stimulus is observed in hundreds of modern drugs, and is referred to as a rebound effect. In this study we propose the utilisation of modern drugs according to the principle of homeopathic cure, employing the rebound effect as a curative reaction. For that we suggest the compilation of a Common Materia Medica that would group all symptoms produced by the medications in human individuals (therapeutic, adverse and side effects), utilising them, a posteriori, following a partial or total similitude, in minimal or ponderous doses. By doing that, we can take advantage of the numerous modern pharmacological compendiums, amplifying the spectrum of homeopathic cure with a wide range of new symptoms and medications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606247     DOI: 10.1016/s0306-9877(02)00386-9

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Brief homeopathic pathogenetic experimentation: a unique educational tool in Brazil.

Authors:  Marcus Zulian Teixeira
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-04       Impact factor: 2.629

2.  Immunology and homeopathy. 5. The rationale of the 'Simile'.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Giuseppina Pitari; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2007-02-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.